Home › Research › Brain scans and imaging
Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain
Kuwabara H, Comley RA, Borroni E, Honer M, Kitmiller K, Roberts J, Gapasin L, Mathur A et al.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018-08-10
Topic: Brain proteins, microglia and lab models
Plain-language summary
The plasma reference graphical analysis appeared to be the optimal method of quantification for 18 F-RO-948, yielding strictly time-consistent values of distribution volume and distribution volume ratio at 90 min against the analyses at 120 and 200 min. The reference tissue graphical analysis and SUV ratio were cross-validated against plasma reference graphical analysis. Test-retest evaluation showed excellent reproducibility. A proposed novel index of tau load, the regional tau-positive fraction, showed high values in the medial and lateral temporal and parietal regions in AD and successfully separated AD subjects from OC and YC subjects with a significant margin. 18 F-RO-948 appears to be a promising radioligand for quantitative imaging of tau in the brain of AD patients.
What this study adds
Evidence grade: Low
This study evaluated a PET radioligand, 18F-RO-948, for measuring tau in the brain, finding it reproducible and able to separate Alzheimer disease subjects from controls. It is about a brain imaging method for measuring tau, not about treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kuwabara, H., Comley, R. A., Borroni, E., Honer, M., Kitmiller, K., Roberts, J., et al. (2018). Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.118.214437
Vancouver
Kuwabara H, Comley RA, Borroni E, Honer M, Kitmiller K, Roberts J, et al. Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2018. doi:10.2967/jnumed.118.214437. PMID: 30097505.
BibTeX
@article{kuwabara2018-30097505,
author = {Kuwabara, H. and Comley, R. A. and Borroni, E. and Honer, M. and Kitmiller, K. and Roberts, J. and Gapasin, L. and Mathur, A. and others},
title = {{Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain}},
journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
year = {2018},
doi = {10.2967/jnumed.118.214437},
pmid = {30097505},
url = {https://doi.org/10.2967/jnumed.118.214437}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The plasma reference graphical analysis appeared to be the optimal method of quantification for 18 F-RO-948, yielding strictly time-consistent values of distribution volume and distribution volume ratio at 90 min against the analyses at 120 and 200 min.
- The reference tissue graphical analysis and SUV ratio were cross-validated against plasma reference graphical analysis.
- Test-retest evaluation showed excellent reproducibility.
- A proposed novel index of tau load, the regional tau-positive fraction, showed high values in the medial and lateral temporal and parietal regions in AD and successfully separated AD subjects from OC and YC subjects with a significant margin. 18 F-RO-948 appears to be a promising radioligand for qua
Why it matters
This study evaluated a PET radioligand, 18F-RO-948, for measuring tau in the brain, finding it reproducible and able to separate Alzheimer disease subjects from controls. It is about a brain imaging method for measuring tau, not about treating, curing or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 44/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of nuclear medicine : official publication, Society of Nuclear Medicine) |
| Journal's citation record | 2 / 4 | Journal of Nuclear Medicine: journal h-index 230 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 80 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 8.0 citations a year over 10 year(s) since 2018 |
| Impact for its field and year | 3 / 6 | Cited 5.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 2 / 4 | Cited 19 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Dean Foster Wong: h-index 85 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 30097505) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.2967/jnumed.118.214437
- PubMed: 30097505
- Original source →
- Free full text: Journal of Nuclear Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Brain scans and imaging from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.